Document is current

Article History

Received: 10 September 2024

Accepted: 20 February 2025

First Online: 25 February 2025

Declarations

:

: Financial: Sophie Lehnerer has received speakers´ honoraria from Alexion, argenx, Hormosan and UCB and honoraria for attendance at advisory boards from Alexion, argenx, Biogen, UCB and Roche. Meret Herdick has received speaker’s honaria from argenx and alexion and a honoraria for attending advisory board from alexion. Maike Stein has received speaker´s honoraria and honoraria for attendance at advisory boards from argenx and Alexion. Andreas Meisel has received speaker or consultancy honoraria or financial research support (paid to his institution) from Alexion Pharmaceuticals, argenx, Axunio, Destin, Grifols, Hormosan, Pharma, Janssen, Merck, Octapharma, Novartis, Sanofi, UCB, Sand Xcenda. Lars Joeres was a former employee of UCB Pharma and Jutta Biskup is a current employee UCB Pharma. All other authors report no disclosures relevant to the manuscript. Non-financial: Andreas Meisel serves as medical advisory board chairman of the German Myasthenia Gravis Society.

: The study was conducted in accordance to the declaration of Helsinki and received ethics approval by the institutional ethics committee of Charité- Universitätsmedizin Berlin (EA1/008/19) as well as registered on drks.de (DRKS00024527). Due to the non-interventional, retrospective nature of the analyzed data and because our analysis was based on an anonymized dataset, neither ethical review nor informed consent of the patients was required according to German national legislation (§ 75 SGB X).

: Data (“DMG dataset”) were obtained by a large questionnaire-based survey. No written informed consent was obtained from the study participants because the data collection was completely anonymous (ethics committee of Charité - Universitätsmedizin Berlin (EA1/008/19)). The study was conducted in accordance to the declaration of Helsinki and received ethics approval by the institutional ethics committee of Charité- Universitätsmedizin Berlin (EA1/008/19) as well as registered on drks.de (DRKS00024527). Due to the non-interventional, retrospective nature of the analyzed data and because our analysis was based on an anonymized dataset, neither ethical review nor informed consent of the patients was required according to German national legislation (§ 75 SGB X).

: All authors have approved the manuscript for submission, accordingly the manuscript conforms to the journal´s policies. The authors take full responsibility for the data, the analyses and interpretation, and the conduct of the research. They have full access to all of the data, and the right to publish any and all data separate and apart from the guidance of any sponsor.